Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Ravassa, S. (Susana) | - |
dc.creator | Garcia-Bolao, I. (Ignacio) | - |
dc.creator | Zudaire, A. (Amaia) | - |
dc.creator | Macias, A. (Alfonso) | - |
dc.creator | Gavira, J.J. (Juan José) | - |
dc.creator | Beaumont, J. (Javier) | - |
dc.creator | Arias, T. (Teresa) | - |
dc.creator | Huerta, A. (Ana) | - |
dc.creator | Diez-Martinez, J. (Javier) | - |
dc.date.accessioned | 2012-04-30T10:19:02Z | - |
dc.date.available | 2012-04-30T10:19:02Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | Ravassa S, Garcia-Bolao I, Zudaire A, Macias A, Gavira JJ, Beaumont J, et al. Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. Cardiovasc Res 2010 Nov 1;88(2):304-313. | es_ES |
dc.identifier.issn | 1755-3245 | - |
dc.identifier.uri | https://hdl.handle.net/10171/21831 | - |
dc.description.abstract | AIMS: Cardiac resynchronization therapy (CRT) diminishes cardiac apoptosis and improves systolic function in heart failure (HF) patients with ventricular dyssynchrony. Plasma annexin A5 (AnxA5), a protein related to cellular damage, is associated with systolic dysfunction. We investigated whether the response to CRT is associated with plasma AnxA5. We also studied AnxA5 overexpression effects in HL-1 cardiomyocytes. METHODS AND RESULTS: AnxA5 ELISA was performed in plasma from 57 patients with HF and ventricular dyssynchrony at baseline and after 1 year of CRT. Patients were categorized as responders if they presented both a reduction in left ventricular (LV) end-systolic volume index (LVESVi) >10% and an increase in LV ejection fraction (LVEF) >10%. HL-1 cells were transfected with human AnxA5 cDNA, and AnxA5, PKC, Akt, p38MAPK, Bcl-2, mitochondrial integrity, caspase-3, and ATP were assessed. At baseline, an increased plasma AnxA5 level was associated with decreased LVEF and increased LVEDVi values (P < 0.05). No differences in baseline AnxA5 were observed between responders and non-responders. After CRT, AnxA5 decreased (P = 0.001) in responders but remained unchanged in non-responders. Final values of AnxA5 were independently associated with LVEF (r = -0.387, P = 0.003) and LVESVi (r = 0.403, P = 0.004) in all patients. Compared with control cells, AnxA5-transfected cells exhibited AnxA5 overexpression, decreased PKC and Akt and increased p38MAPK and Bcl-2 phosphorylation, loss of mitochondrial integrity, caspase-3 activation, and decreased ATP. CONCLUSION: CRT-induced LV reverse remodelling is associated with reduction in plasma AnxA5. The excess of AnxA5 is detrimental for HL-1 cardiomyocytes. Collectively, these data suggest that the beneficial effects of CRT might be related to an AnxA5 decrease. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Oxford University Press | es_ES |
dc.rights | info:eu-repo/semantics/closedAccess | - |
dc.subject | Annexin A5 | es_ES |
dc.subject | Mitochondrial dysfunction | es_ES |
dc.subject | Heart failure | es_ES |
dc.subject | Resynchronization | es_ES |
dc.subject | Ventricular dyssynchrony | es_ES |
dc.title | Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5 | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | http://cardiovascres.oxfordjournals.org/content/88/2/304 | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.